1. Home
  2. CAKE vs MIRM Comparison

CAKE vs MIRM Comparison

Compare CAKE & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAKE
  • MIRM
  • Stock Information
  • Founded
  • CAKE 1972
  • MIRM 2018
  • Country
  • CAKE United States
  • MIRM United States
  • Employees
  • CAKE N/A
  • MIRM N/A
  • Industry
  • CAKE Restaurants
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAKE Consumer Discretionary
  • MIRM Health Care
  • Exchange
  • CAKE Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • CAKE 2.8B
  • MIRM 2.5B
  • IPO Year
  • CAKE 1992
  • MIRM 2019
  • Fundamental
  • Price
  • CAKE $64.67
  • MIRM $52.66
  • Analyst Decision
  • CAKE Hold
  • MIRM Strong Buy
  • Analyst Count
  • CAKE 14
  • MIRM 9
  • Target Price
  • CAKE $53.71
  • MIRM $66.22
  • AVG Volume (30 Days)
  • CAKE 1.4M
  • MIRM 456.2K
  • Earning Date
  • CAKE 07-29-2025
  • MIRM 08-06-2025
  • Dividend Yield
  • CAKE 1.67%
  • MIRM N/A
  • EPS Growth
  • CAKE 45.67
  • MIRM N/A
  • EPS
  • CAKE 3.19
  • MIRM N/A
  • Revenue
  • CAKE $3,617,673,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • CAKE $7.04
  • MIRM $35.83
  • Revenue Next Year
  • CAKE $6.10
  • MIRM $16.83
  • P/E Ratio
  • CAKE $20.30
  • MIRM N/A
  • Revenue Growth
  • CAKE 4.42
  • MIRM 69.31
  • 52 Week Low
  • CAKE $33.50
  • MIRM $36.17
  • 52 Week High
  • CAKE $65.99
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • CAKE 66.81
  • MIRM 64.66
  • Support Level
  • CAKE $62.87
  • MIRM $49.22
  • Resistance Level
  • CAKE $65.41
  • MIRM $53.86
  • Average True Range (ATR)
  • CAKE 1.79
  • MIRM 1.57
  • MACD
  • CAKE -0.03
  • MIRM 0.08
  • Stochastic Oscillator
  • CAKE 79.26
  • MIRM 79.63

About CAKE Cheesecake Factory Incorporated (The)

Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: